A two-stage sampling method for clinical surveillance of individuals in care for HIV infection in the United States

Public Health Reports

Volumn 120, Issue 3, 2005, Pages 230-239

  Sullivan, Patrick S ^a,g   Karon, John M ^a   Malitz, Faye E ^b   Broyles, Stephanie ^c   Mokotoff, Eve D ^d   Buskin, Susan E ^e,f   Fleming, Patricia L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^c Louisiana Office of Public Health   (United States)

^d MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^e Pub Health Seattle and King County   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; DEMOGRAPHY; FEMALE; HEALTH CARE; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLING; UNITED STATES;

EID: 18244404800     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1177/003335490512000304     Document Type: Article

References (29)

1. Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 2001;285:1308-15.
2. Report of the NIH panel to define principles of therapy of HIV infection. MMWRRecomm Rep 1998;47(RR-13):1-41.
3. Summers T, Alagiri P, Kates J. Federal HIV/AIDS spending: a budget chartbook, fiscal year 2002. Menlo Park (CA): The Henry J. Kaiser Family Foundation; 2003. Also available from: URL: http://www.kff.org/hivaids/loader. cfm?url=/commonspot/security/getfile.cfm&PageID=21717 [cited 2005 Jan 20].
4. Shapiro MF, Berk ML, Berry SH, Emmons CA, Athey LA, Hsia DC, et al. National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study. Health ServRes 1999;34(5 Part 1):951-68.
5. Frankel MR, Shapiro MF, Duan N, Morton SC, Berry SH, Brown JA, et al. National probability samples in studies of low-prevalence diseases. Part II: designing and implementing the HIV cost and services utilization study sample. Health Serv Res 1999;34(5 Part 1):969-92.
6. Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, Hopkins SG, et al. Spectrum of disease in individuals with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-805.
7. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999;48(2):1-22.
8. McNaghten AD, Hanson DL, Jones DL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999;13:1687-95.
9. Louisiana Department of Health and Hospitals. Administrative regions [cited 2005 Jan 15]. Available from: URL: http://www .dhh.louisiana.gov/offices/ medialibrary/media-1/REG_MAP04.jpg
10. Department of Health and Human Services (US), HIV/AIDS Bureau. Ryan White CARE Act [cited 2005 Jan 15]. Available from: URL: http://hab/hrsa.gov/history. htm
11. Insightful Corporation. S-PLUS: Version 6. Washington: Insightful Corporation; 2003.
12. SAS Institute. SAS: Version 8.2. Cary (NC): SAS Institute; 2002.
13. Research Triangle Institute. SUDAAN user manual, release 8.0. Research Triangle Park (NC): Research Triangle Institute; 2001.
14. Cochran WG. Sampling techniques. New York: John Wiley & Sons; 1977.
15. Moore RD, Stanton D, Gopalan R, Chiasson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994;330:763-8.
16. Hsu LC, Vittinghoff E, Katz MH, Schwarcz SK. Predictors of use of highly active antiretroviral therapy (HAART) among individuals with AIDS in San Francisco, 1996-1999. J Acquir Immune Defic Syndr 2001;28:345-50.
17. Klevens RM, Fleming PL, Li J, Gaines CG, Gallagher K, Schwarcz K, et al. The completeness, validity, and timeliness of AIDS surveillance data. Ann Epidemiol 2001;11:443-9.
18. United States Public Health Service and Infectious Disease Society of America. USPHS/IDSA guidelines for the prevention of opportunistic infections in individuals infected with human immunodeficiency virus [cited 2005 Jan 15]. Available from: URL: http://aidsinfo.nih.gov/guidelines/default_db2.asp?id=69
19. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41 (RR-17):1-19.
20. Kaplan JE, Hanson DL, Jones JL. Early initiation of combination antiretroviral therapy: does it affect clinical outcome? Proceeding of the 13th International AIDS Conference; 2000 July; Durban, South Africa. Abstract No.: LbPeB7051.
21. Dworkin MS, Hanson DL, Kaplan JE, Jones JL, Ward JW. Risk for preventable opportunistic infections in individuals with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds. J Infect Dis 2000;182:611-5.
22. Kaplan JE, Hanson JL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J Infect Dis 1998;178:1126-32.
23. Brooks JT. Risk of Mycobacterium avium complex (MAC) infection among HIV-infected individuals who stop primary prophylaxis after HAART-associated immune reconstitution. Proceedings of the Infectious Diseases Society of America 40th Annual Meeting; 2000; San Diego (CA). Abstract No.: 500.
24. Blair J, Hanson DL, Jones JL. Do gender differences in viral load predict differences in HIV disease progression? Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections; 2000 Feb; San Francisco. Abstract No.: 195.
25. Bozzette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998;339:1897-904.
26. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 2003;32 Suppl 1:S68-S85.
27. Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005 [cited 2005 Jan 15]. Available from: URL: www.cdc.gov/nchstp/od/ hiv_plan
28. Hansen MH, Hurwitz WN, Madow WG. Sample survey methods and theory. New York: John Wiley & Sons; 1953.
29. Kish L. Survey sampling. New York: John Wiley; 1965.